Related Experiment Video

Updated: Dec 29, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.6K

Cardiac-Specific Caveolin-3 Overexpression Prevents Post-Myocardial Infarction Ventricular Arrhythmias by Inhibiting

Zhihao Zhang1, Qin Fang1, Tingyi Du1

  • 1Division of Cardiology, Departments of Internal Medicine and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Cardiology
|February 3, 2020
PubMed

Insights

Caveolin-3 (Cav3) overexpression in the heart reduces life-threatening ventricular arrhythmias and sudden cardiac death (SCD) after myocardial infarction (MI). This finding identifies Cav3 as a potential therapeutic target for preventing SCD post-MI.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cardiac Electrophysiology

Background:

  • Ventricular arrhythmias pose a significant risk for sudden cardiac death (SCD) following acute myocardial infarction (MI).
  • The precise molecular mechanisms driving these arrhythmias remain incompletely understood.
  • Caveolin-3 (Cav3), a structural protein of caveolae, is investigated for its potential role in managing ventricular arrhythmias.

Purpose of the Study:

  • To investigate the role of cardiac-specific caveolin-3 (Cav3) overexpression in preventing ventricular arrhythmias and SCD post-myocardial infarction (MI).
  • To elucidate the molecular mechanisms by which Cav3 influences cardiac arrhythmogenesis.

Main Methods:

  • Established a mouse model with cardiac-specific Cav3 overexpression using recombinant adeno-associated viral vectors.
  • Utilized calcium (Ca2+) imaging to assess cardiomyocyte arrhythmogenic propensity.
  • Employed immunoprecipitation, immunofluorescence, qRT-PCR, and western blotting to analyze protein interactions and expression levels.

Main Results:

  • Cardiac-specific Cav3 overexpression significantly reduced the incidence of ventricular arrhythmias and SCD in mice post-MI.
  • Cav3 overexpression inhibited diastolic spontaneous Ca2+ waves by reducing ryanodine receptor-2 (RyR2) hyperphosphorylation at Ser2814.
  • Cav3-mediated RyR2 regulation was found to depend on plakophilin-2 in hypoxia-stimulated cardiomyocytes.

Conclusions:

  • Caveolin-3 plays a novel protective role in preventing ventricular arrhythmias after myocardial infarction.
  • Cav3 emerges as a potential therapeutic target for reducing sudden cardiac death risk post-MI.
Abstract

Keywords:
Caveolin-3Myocardial infarctionPlakophilin-2Ryanodine receptor-2Ventricular arrhythmias

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.5K
Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

20.9K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
427